Annalisa Jenkins - 29 Feb 2024 Form 3 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
Issuer symbol
SKYE
Transactions as of
29 Feb 2024
Net transactions value
$0
Form type
3
Filing time
04 Mar 2024, 16:18:23 UTC
Previous filing
09 Feb 2024
Next filing
03 May 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney